ABCG8 (Q9H221) variants and mutations
ABCG8 (also known as Q9H221) is a human protein-coding gene encoding an ATP-binding cassette sub-family G member 8 protein. Together with ABCG5, it drives sterol efflux from hepatocytes and enterocytes, limiting absorption and promoting biliary elimination of cholesterol and plant sterols. Biallelic loss-of-function variants cause sitosterolemia and can lead to premature atherosclerotic cardiovascular disease. This analysis covers 1,424 ABCG8 variants and mutations. Of these, 73% have computational variant effect predictions. Disease context includes sitosterolemia, sitosterolemia 1, and cholelithiasis. Example ABCG8 variants include M1I, M1T, and A2T.
Variant analysis overview
- Gene: ABCG8
- Protein: Q9H221
- UniProt accession: Q9H221
- Organism: Homo sapiens
- Variants analyzed: 1424
- Variant scope: all variants
- Completed: 2026-08-20
Variant and mutation evidence
- Variant composition: 1,257 unspecified-consequence records; 91 missense variants; 53 synonymous variants; 11 frameshift variants; 7 stop-gained variants; 3 in-frame deletions; 2 splice-region variants
- Prediction scores: 1,046 variants have prediction scores (73% of the analyzed set).
Clinical, disease, and population context
- Disease context: 25 disease associations are represented. Top associations: sitosterolemia, sitosterolemia 1, cholelithiasis, Hypercholesterolemia, Abnormality of the cardiovascular system, Disorder of lipid metabolism, Cholecystitis, gallstones, response to statin, metabolic disease, coronary artery disorder, gallbladder disorder.
Protein structure and variant hotspots
- Protein features: 6 transmembrane segments; 2 domains; 1 post-translational modification sites.
- Structural context: 1,047 variants have structural context.
Data sources
Evidence in this analysis draws on EBI Proteins Variation, UniProt, gnomAD v4, EuropePMC, 3D Hotspot Analysis, Interaction Network Analysis, Protein Data Bank, AlphaFold DB, gnomAD constraint, Open Targets, ClinGen, MaveDB, LitVar.
Notable ABCG8 variants
Examples include M1I, M1T, A2T, A2S, A2D, A2V, A2A, G3A. Listed records include available protein-change notation, database identifiers, clinical classifications, computational predictions, population evidence, experimental measurements, and disease context.
- M1I (p.Met1Ile), rs1365569134, ClinGen CA346662349, ClinVar RCV005100940, ClinVar RCV006262337, Uncertain significance, not specified; not provided
- M1T (p.Met1Thr), rs538699999, ClinGen CA1636850, ClinVar RCV002224309, ClinVar RCV002466278, Conflicting interpretations, Sitosterolemia 1; not provided
- A2T (p.Ala2Thr), NCI-TCGA Cosmic COSV5321, cosmic curated COSV53210, REVEL 0.25, CADD 15.10, Variant assessed as somatic; moderate impact.
- A2S (p.Ala2Ser), gnomAD 2-43839057-G-T, REVEL 0.26, MetaLR 0.47
- A2D (p.Ala2Asp), gnomAD 2-43839058-C-A, REVEL 0.32, MetaLR 0.61
- A2V (p.Ala2Val), gnomAD 2-43839058-C-T, REVEL 0.47, MetaLR 0.49
- A2A (p.Ala2Ala), rs954982677, gnomAD 2-43839059-C-G, CADD 5.19
- G3A (p.Gly3Ala), ExAC rs778143236, TOPMed rs778143236, gnomAD rs778143236, REVEL 0.22, CADD 4.97
- G3E (p.Gly3Glu), ExAC rs778143236, TOPMed rs778143236, gnomAD rs778143236, REVEL 0.26, CADD 1.02
- G3R (p.Gly3Arg), rs1009122651, ClinGen CA46426857, NCI-TCGA Cosmic COSV5321, cosmic curated COSV53210, REVEL 0.22, CADD 16.50, Uncertain significance, not provided
- G3V (p.Gly3Val), ExAC rs778143236, TOPMed rs778143236, gnomAD rs778143236, REVEL 0.22, CADD 11.60
- G3W (p.Gly3Trp), NCI-TCGA Cosmic COSV5321, REVEL 0.26, CADD 23.30, Variant assessed as somatic; moderate impact.
- G3G (p.Gly3Gly), gnomAD 2-43839062-G-A, CADD 6.62
- K4Q (p.Lys4Gln), gnomAD 2-43832599-A-C, CADD 5.14, SIFT 0.13
- K4N (p.Lys4Asn), gnomAD 2-43839065-G-T, REVEL 0.12, MetaLR 0.43
- K4K (p.Lys4Lys), rs1226302403, gnomAD 2-43839065-G-A, CADD 2.42
- A5G (p.Ala5Gly), TOPMed rs1447413028, gnomAD rs1447413028, Likely benign
- A5S (p.Ala5Ser), 1000Genomes rs201317673, TOPMed rs201317673, gnomAD rs201317673
- A5T (p.Ala5Thr), 1000Genomes rs201317673, TOPMed rs201317673, gnomAD rs201317673, REVEL 0.11, CADD 4.99
- A5V (p.Ala5Val), TOPMed rs1447413028, gnomAD rs1447413028, REVEL 0.14, CADD 0.50, Likely benign, Cardiovascular phenotype
- A5E (p.Ala5Glu), gnomAD 2-43839067-C-A, REVEL 0.35, MetaLR 0.36
- A5A (p.Ala5Ala), rs200951677, gnomAD 2-43839068-G-C, CADD 2.73
- A6V (p.Ala6Val), TOPMed rs1572813164, REVEL 0.08, CADD 6.67, Uncertain significance, Cardiovascular phenotype
- A6T (p.Ala6Thr), gnomAD 2-43839069-G-A, REVEL 0.15, MetaLR 0.29
- A6S (p.Ala6Ser), gnomAD 2-43839069-G-T, REVEL 0.15, MetaLR 0.28
- A6E (p.Ala6Glu), gnomAD 2-43839070-C-A, REVEL 0.21, MetaLR 0.29
- E7* (p.Glu7Ter), gnomAD rs1244979430, CADD 33.00
- E7D (p.Glu7Asp), rs771255227, ClinGen CA1636853, ClinVar RCV000729574, ClinVar RCV005520341, REVEL 0.18, CADD 3.30, Uncertain significance, Cardiovascular phenotype; not provided
- E7K (p.Glu7Lys), gnomAD rs1244979430, REVEL 0.11, CADD 0.90
- E7V (p.Glu7Val), gnomAD 2-43839073-A-T, REVEL 0.21, MetaLR 0.47
- E7E (p.Glu7Glu), rs771255227, gnomAD 2-43839074-G-A, CADD 1.37
- E8K (p.Glu8Lys), rs1199531123, ClinGen CA346662440, ClinVar RCV002446306, ClinVar RCV005098058, REVEL 0.08, CADD 4.68, Uncertain significance, Sitosterolemia 1; Cardiovascular phenotype; not provided
- E8Q (p.Glu8Gln), rs555401147, gnomAD 2-43832620-G-C, CADD 4.37, SIFT 0.11
- E8* (p.Glu8Ter), gnomAD 2-43832620-G-T, CADD 32.00
- E8E (p.Glu8Glu), gnomAD 2-43832622-G-A, CADD 0.80
- E8D (p.Glu8Asp), gnomAD 2-43839077-G-T, REVEL 0.10, MetaLR 0.46
- R9K (p.Arg9Lys), TOPMed rs954078225, gnomAD rs954078225, REVEL 0.11, CADD 0.35
- R9S (p.Arg9Ser), TOPMed rs984534218, gnomAD rs984534218, CADD 4.63
- R9G (p.Arg9Gly), gnomAD 2-43832611-A-G, CADD 1.50, SIFT 0.04
- R9* (p.Arg9Ter), rs1668020665, gnomAD 2-43832611-A-T, CADD 24.60
- R9I (p.Arg9Ile), gnomAD 2-43832612-G-T, CADD 7.33, SIFT 0.02
- R9T (p.Arg9Thr), gnomAD 2-43839079-G-C, REVEL 0.11, MetaLR 0.28
- R9R (p.Arg9Arg), gnomAD 2-43839080-A-G, CADD 4.13
- G10A (p.Gly10Ala), rs1157337875, ClinGen CA346662482, ClinVar RCV001730333, gnomAD rs1157337875, REVEL 0.09, CADD 2.62, Likely benign, not provided
- G10R (p.Gly10Arg), rs1171068014, ClinGen CA346662474, ClinVar RCV002438053, TOPMed rs1171068014, REVEL 0.17, CADD 8.89, Uncertain significance, Cardiovascular phenotype
- G10V (p.Gly10Val), gnomAD rs1157337875, Likely benign
- G10W (p.Gly10Trp), gnomAD 2-43839081-G-T, REVEL 0.25, MetaLR 0.45
- G10E (p.Gly10Glu), gnomAD 2-43839082-G-A, REVEL 0.08, MetaLR 0.28
- G10G (p.Gly10Gly), rs1668463414, gnomAD 2-43839083-G-A, CADD 4.18
- L11V (p.Leu11Val), rs1016895349, ClinGen CA46426888, ClinVar RCV002322952, TOPMed rs1016895349, REVEL 0.06, CADD 14.00, Uncertain significance, Cardiovascular phenotype
- L11F (p.Leu11Phe), rs1668019200, gnomAD 2-43832596-C-T, CADD 9.20, SIFT 0.15
- L11P (p.Leu11Pro), rs2104868661, gnomAD 2-43832597-T-C, CADD 10.50, SIFT 0.07
- L11L (p.Leu11Leu), rs1038359139, gnomAD 2-43832598-C-A, CADD 0.76
- L11I (p.Leu11Ile), gnomAD 2-43832632-C-A, CADD 0.33, SIFT 0.42
- L11A (p.Leu11Ala), gnomAD 2-43839080-A-AG, CADD 19.10
- L11Q (p.Leu11Gln), gnomAD 2-43839084-C-CAG, CADD 19.40
- L11M (p.Leu11Met), gnomAD 2-43839084-C-A, REVEL 0.09, MetaLR 0.42
- P12L (p.Pro12Leu), rs760005338, ClinGen CA1636855, ClinVar RCV000730773, ExAC rs760005338, REVEL 0.17, CADD 1.50, Uncertain significance, not provided
- P12S (p.Pro12Ser), NCI-TCGA Cosmic COSV5321, cosmic curated COSV53212, Variant assessed as somatic; moderate impact.
- P12T (p.Pro12Thr), gnomAD 2-43832602-C-A, CADD 2.27, SIFT 0.07
- P12A (p.Pro12Ala), rs1668019979, gnomAD 2-43832602-C-CCGC, CADD 15.40
- P12R (p.Pro12Arg), rs1203870654, gnomAD 2-43832603-C-G, CADD 1.04, SIFT 0.03
- P12P (p.Pro12Pro), rs923318288, gnomAD 2-43832604-G-A, CADD 1.01
- P12Q (p.Pro12Gln), gnomAD 2-43832609-C-A, CADD 0.51, SIFT 0.00
- K13* (p.Lys13Ter), gnomAD 2-43839090-A-T, CADD 32.00
- K13N (p.Lys13Asn), gnomAD 2-43839092-A-C, REVEL 0.16, MetaLR 0.25
- G14A (p.Gly14Ala), rs773804452, ClinGen CA346662537, ClinVar RCV003177192, Uncertain significance, Cardiovascular phenotype
- G14E (p.Gly14Glu), ExAC rs773804452, gnomAD rs773804452, REVEL 0.10, CADD 0.17
- G14W (p.Gly14Trp), gnomAD 2-43839093-G-T, REVEL 0.29, MetaLR 0.58
- G14R (p.Gly14Arg), gnomAD 2-43839093-G-A, REVEL 0.12, MetaLR 0.38
- G14V (p.Gly14Val), gnomAD 2-43839094-G-T, REVEL 0.13, MetaLR 0.37
- G14G (p.Gly14Gly), rs1415052353, gnomAD 2-43839095-G-T, CADD 1.05
- A15T (p.Ala15Thr), rs761344788, ClinGen CA1636858, NCI-TCGA Cosmic COSV9957, cosmic curated COSV99575, REVEL 0.25, CADD 0.12, Likely benign, Cardiovascular phenotype
- A15V (p.Ala15Val), rs942518094, gnomAD 2-43832618-C-T, CADD 4.72, SIFT 0.25
- A15A (p.Ala15Ala), gnomAD 2-43832619-T-C, CADD 7.09
- A15S (p.Ala15Ser), gnomAD 2-43832626-G-T, CADD 1.03, SIFT 0.69
- A15P (p.Ala15Pro), gnomAD 2-43839089-GA-G, CADD 10.80
- A15D (p.Ala15Asp), gnomAD 2-43839097-C-A, REVEL 0.23, MetaLR 0.45
- T16A (p.Thr16Ala), TOPMed rs1189494830, REVEL 0.20, CADD 0.46
- T16I (p.Thr16Ile), gnomAD rs1303867159
- T16L (p.Thr16Leu), gnomAD 2-43839096-GC-G, CADD 20.80
- T16N (p.Thr16Asn), gnomAD 2-43839100-C-A, REVEL 0.14, MetaLR 0.33
- P17H (p.Pro17His), cosmic curated COSV99575, TOPMed rs1668464811, REVEL 0.29, CADD 15.50
- P17S (p.Pro17Ser), TOPMed rs1668464670, REVEL 0.14, CADD 2.52
- P17T (p.Pro17Thr), TOPMed rs1668464670, REVEL 0.26, CADD 2.21
- P17del (p.Pro17del), gnomAD 2-43839099-ACTC-A, CADD 5.83
- P17A (p.Pro17Ala), gnomAD 2-43839102-C-G, REVEL 0.15, MetaLR 0.31
- P17L (p.Pro17Leu), gnomAD 2-43839103-C-T, REVEL 0.19, MetaLR 0.33
- P17P (p.Pro17Pro), rs72647316, gnomAD 2-43839104-C-A, CADD 4.70
- Q18* (p.Gln18Ter), rs2466158443, ClinGen CA346662585, ClinVar RCV003849506, Pathogenic
- Q18R (p.Gln18Arg), gnomAD 2-43832591-A-G, CADD 8.84, SIFT 0.00
- Q18L (p.Gln18Leu), gnomAD 2-43832591-A-T, CADD 10.50, SIFT 0.00
- Q18H (p.Gln18His), gnomAD 2-43832592-G-T, CADD 12.90, SIFT 0.00
- Q18K (p.Gln18Lys), gnomAD 2-43832635-C-A, CADD 0.32, SIFT 0.92
- Q18Q (p.Gln18Gln), gnomAD 2-43832637-G-A, CADD 0.76
- D19H (p.Asp19His), rs11887534, ClinGen CA117156, cosmic curated COSV53211, ClinVar RCV000005263, REVEL 0.36, CADD 23.40, Benign/Likely benign; association, Cardiovascular phenotype; Sitosterolemia 1; Sitosterolemia 2
- D19N (p.Asp19Asn), 1000Genomes rs11887534, ESP rs11887534, ExAC rs11887534, TOPMed rs11887534, REVEL 0.17, CADD 18.60, Pathogenic
- D19R (p.Asp19Arg), gnomAD 2-43839107-GGATAC, CADD 23.90
- D19E (p.Asp19Glu), gnomAD 2-43839110-T-G, REVEL 0.14, MetaLR 0.30
- T20A (p.Thr20Ala), rs911173521, gnomAD 2-43832653-A-G, CADD 0.82, SIFT 0.79
- T20I (p.Thr20Ile), rs1558766692, gnomAD 2-43832654-C-T, CADD 5.78, SIFT 0.19
- T20N (p.Thr20Asn), gnomAD 2-43839112-C-A, REVEL 0.10, MetaLR 0.32
- T20T (p.Thr20Thr), gnomAD 2-43839113-C-A, CADD 2.70
- S21* (p.Ser21Ter), 1000Genomes rs144411000, ExAC rs144411000, TOPMed rs144411000, gnomAD rs144411000, CADD 32.00, Likely benign
- S21L (p.Ser21Leu), rs144411000, ClinGen CA1636859, cosmic curated COSV10455, ClinVar RCV000729605, REVEL 0.18, CADD 2.89, Conflicting interpretations, Cardiovascular phenotype; Sitosterolemia 1; not provided
- S21T (p.Ser21Thr), Ensembl rs2104901890, REVEL 0.23, CADD 7.16
- S21I (p.Ser21Ile), rs912404677, gnomAD 2-43832594-G-T, CADD 3.67, SIFT 0.00
- S21R (p.Ser21Arg), rs1475754258, gnomAD 2-43832595-C-G, CADD 1.53, SIFT 0.00
- S21S (p.Ser21Ser), gnomAD 2-43832625-A-G, CADD 1.79
- S21P (p.Ser21Pro), gnomAD 2-43832638-T-C, CADD 8.17, SIFT 0.19
- S21W (p.Ser21Trp), rs897245516, gnomAD 2-43832639-C-G, CADD 11.30, SIFT 0.01
- S21G (p.Ser21Gly), gnomAD 2-43832650-A-G, CADD 7.52, SIFT 0.26
- S21N (p.Ser21Asn), gnomAD 2-43832651-G-A, CADD 5.21, SIFT 0.24
- G22D (p.Gly22Asp), cosmic curated COSV10723, NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- G22S (p.Gly22Ser), rs373228989, ClinGen CA1636881, ClinVar RCV002011760, ClinVar RCV002361393, REVEL 0.18, CADD 22.20, Uncertain significance, not provided; Cardiovascular phenotype; Sitosterolemia 1
- G22C (p.Gly22Cys), gnomAD 2-43832656-G-T, CADD 10.90, SIFT 0.03
- G22G (p.Gly22Gly), gnomAD 2-43832658-C-T, CADD 3.60
- G22P (p.Gly22Pro), gnomAD 2-43839103-C-CCCA, CADD 21.00
- L23F (p.Leu23Phe), gnomAD 2-43832646-G-T, CADD 4.14, SIFT 0.57
- L23L (p.Leu23Leu), gnomAD 2-43832646-G-A, CADD 1.94
- Q24R (p.Gln24Arg), gnomAD rs1668679276, REVEL 0.27, CADD 22.20
- Q24L (p.Gln24Leu), rs1558796289, gnomAD 2-43844509-CCTCCA, CADD 29.70
- Q24Q (p.Gln24Gln), rs752736081, gnomAD 2-43844515-G-A, CADD 8.49
- D25N (p.Asp25Asn), NCI-TCGA Cosmic COSV5539, cosmic curated COSV55390, Variant assessed as somatic; moderate impact.
- D25Y (p.Asp25Tyr), cosmic curated COSV55395
- D25G (p.Asp25Gly), gnomAD 2-43844517-A-G, REVEL 0.43, MetaLR 0.72
- R26G (p.Arg26Gly), rs138925418, ClinGen CA1636883, ClinVar RCV000594891, ClinVar RCV001143575, REVEL 0.18, CADD 22.70, Uncertain significance, Sitosterolemia 1; not provided
- R26I (p.Arg26Ile), ExAC rs778043042, gnomAD rs778043042, REVEL 0.24, CADD 22.60, Uncertain significance, Cardiovascular phenotype
- R26K (p.Arg26Lys), NCI-TCGA Cosmic COSV5539, cosmic curated COSV55396, REVEL 0.19, CADD 18.90, Variant assessed as somatic; moderate impact.
- R26T (p.Arg26Thr), NCI-TCGA Cosmic COSV5539, Variant assessed as somatic; moderate impact.
- R26R (p.Arg26Arg), gnomAD 2-43844521-A-G, CADD 9.53
- L27F (p.Leu27Phe), ExAC rs751787457, gnomAD rs751787457, REVEL 0.11, CADD 17.40, Uncertain significance, Cardiovascular phenotype
- L27V (p.Leu27Val), TOPMed rs879383949, gnomAD rs879383949, REVEL 0.14, CADD 15.10, Likely benign
- L27L (p.Leu27Leu), rs879383949, gnomAD 2-43844522-T-C, CADD 7.73
- F28L (p.Phe28Leu), rs1362946455, gnomAD rs1362946455, Variant assessed as somatic; moderate impact.
- S29F (p.Ser29Phe), NCI-TCGA TCGA novel, Variant assessed as somatic; moderate impact.
- S30del (p.Ser30del), gnomAD 2-43844526-TCTC-T, CADD 17.60
- S30A (p.Ser30Ala), gnomAD 2-43844531-T-G, REVEL 0.26, MetaLR 0.51
- E31A (p.Glu31Ala), rs1474416976, ClinGen CA346663092, ClinVar RCV002371509, gnomAD rs1474416976, REVEL 0.68, CADD 26.60, Uncertain significance, Cardiovascular phenotype
- E31K (p.Glu31Lys), NCI-TCGA Cosmic COSV5539, cosmic curated COSV55396, Variant assessed as somatic; moderate impact.
- S32C (p.Ser32Cys), 1000Genomes rs148370122, ESP rs148370122, ExAC rs148370122, TOPMed rs148370122, Benign
- S32G (p.Ser32Gly), rs148370122, ClinGen CA1636886, ClinVar RCV000403947, ClinVar RCV000967641, REVEL 0.21, CADD 21.10, Benign/Likely benign, not provided; Sitosterolemia 1; Cardiovascular phenotype
- S32T (p.Ser32Thr), gnomAD 2-43844538-G-C, REVEL 0.25, MetaLR 0.34
- D33A (p.Asp33Ala), Ensembl rs1572823105
- D33E (p.Asp33Glu), rs746154054, ClinGen CA346663133, ClinVar RCV003301859, ExAC rs746154054, REVEL 0.50, CADD 24.40, Uncertain significance, Cardiovascular phenotype
- D33G (p.Asp33Gly), NCI-TCGA Cosmic COSV9969, cosmic curated COSV99699, REVEL 0.76, CADD 27.20, Variant assessed as somatic; moderate impact.
- D33N (p.Asp33Asn), rs148456883, ClinGen CA1636887, ClinVar RCV000591513, ClinVar RCV001336053, REVEL 0.41, CADD 29.20, Uncertain significance, Gallbladder disease 4; Sitosterolemia 1; not specified
- D33D (p.Asp33Asp), rs746154054, gnomAD 2-43844542-C-T, CADD 10.30
- N34D (p.Asn34Asp), rs897087769, ClinGen CA346663141, ClinVar RCV003079334, ClinVar RCV004661556, REVEL 0.33, CADD 22.40, Uncertain significance, Cardiovascular phenotype; Sitosterolemia 1; not provided
- N34H (p.Asn34His), TOPMed rs897087769, gnomAD rs897087769, Uncertain significance
- N34S (p.Asn34Ser), ExAC rs76972450, gnomAD rs76972450, REVEL 0.24, CADD 18.40
- N34T (p.Asn34Thr), ExAC rs76972450, gnomAD rs76972450, REVEL 0.42, CADD 23.00
- N34K (p.Asn34Lys), gnomAD 2-43844545-C-A, REVEL 0.44, MetaLR 0.60
- S35G (p.Ser35Gly), gnomAD rs1462924756, REVEL 0.53, CADD 24.40
- S35I (p.Ser35Ile), cosmic curated COSV55394
- S35N (p.Ser35Asn), TOPMed rs1329698673, gnomAD rs1329698673, REVEL 0.40, CADD 25.10
- L36V (p.Leu36Val), ExAC rs780526039, TOPMed rs780526039, gnomAD rs780526039, REVEL 0.58, CADD 23.70
- L36L (p.Leu36Leu), rs780526039, gnomAD 2-43844549-C-T, CADD 9.06
- L36P (p.Leu36Pro), gnomAD 2-43844550-T-C, REVEL 0.78, MetaLR 0.77
- Y37* (p.Tyr37Ter), gnomAD 2-43844554-C-A, CADD 37.00
- F38C (p.Phe38Cys), Ensembl rs1558796477, REVEL 0.75, CADD 28.40
- F38L (p.Phe38Leu), gnomAD 2-43844557-C-A, REVEL 0.58, MetaLR 0.48
- T39I (p.Thr39Ile), ExAC rs749860873, gnomAD rs749860873, REVEL 0.62, CADD 24.40
- T39S (p.Thr39Ser), ExAC rs749860873, gnomAD rs749860873, REVEL 0.46, CADD 23.80
- Y40* (p.Tyr40Ter), rs1000291485, Ensembl rs1000291485, ClinGen CA346663238, ClinVar RCV000594922, Pathogenic
- Y40C (p.Tyr40Cys), ExAC rs771547389, gnomAD rs771547389, REVEL 0.81, CADD 27.70
- Y40F (p.Tyr40Phe), gnomAD 2-43844562-A-T, REVEL 0.59, MetaLR 0.63
- S41N (p.Ser41Asn), rs772660192, ClinGen CA346663246, ClinVar RCV001890454, ClinVar RCV004041270, REVEL 0.32, CADD 23.00, Uncertain significance, Cardiovascular phenotype; not provided
- S41T (p.Ser41Thr), ExAC rs772660192, TOPMed rs772660192, gnomAD rs772660192, REVEL 0.27, CADD 21.40, Uncertain significance
- G42V (p.Gly42Val), TOPMed rs1033059139, gnomAD rs1033059139, REVEL 0.71, CADD 26.40, Uncertain significance, Cardiovascular phenotype
- Q43* (p.Gln43Ter), TOPMed rs1464989976
- Q43H (p.Gln43His), ESP rs367887512, ExAC rs367887512, TOPMed rs367887512, gnomAD rs367887512, REVEL 0.18, CADD 8.77
- Q43R (p.Gln43Arg), gnomAD rs1477765060, REVEL 0.17, CADD 0.34
- P44H (p.Pro44His), gnomAD rs1470061328, REVEL 0.26, CADD 23.70
- P44T (p.Pro44Thr), rs770421664, ClinGen CA1636895, ClinVar RCV000731763, ExAC rs770421664, REVEL 0.12, CADD 10.30, Uncertain significance, not provided
- P44L (p.Pro44Leu), gnomAD 2-43844574-C-T, REVEL 0.26, MetaLR 0.47
- P44P (p.Pro44Pro), gnomAD 2-43844575-C-T, CADD 7.46
- N45H (p.Asn45His), Ensembl rs1572823215
- N45T (p.Asn45Thr), Ensembl rs1668681980
- T46A (p.Thr46Ala), ExAC rs776356685, gnomAD rs776356685, REVEL 0.30, CADD 18.90
Public ABCG8 analysis runs
- ABCG8 analysis run — ABCG8 (1,424 variants) — completed 2026-08-20